Kristen Alexander - Feb 28, 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Finance and Accounting
Signature
/s/ Kristen L. Alexander
Stock symbol
LXRX
Transactions as of
Feb 28, 2025
Transactions value $
-$11,968
Form type
4
Date filed
3/3/2025, 04:33 PM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +10.6K +22.21% 58.4K Feb 28, 2025 Direct F1
transaction LXRX Common Stock Options Exercise +15.9K +27.26% 74.3K Feb 28, 2025 Direct F1
transaction LXRX Common Stock Options Exercise +19.9K +26.75% 94.2K Feb 28, 2025 Direct F1
transaction LXRX Common Stock Tax liability -$12K -17.9K -18.96% $0.67 76.4K Feb 28, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -10.6K -100% 0 Feb 28, 2025 Common Stock 10.6K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -15.9K -50% 15.9K Feb 28, 2025 Common Stock 15.9K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -19.9K -33.33% 39.8K Feb 28, 2025 Common Stock 19.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.